文献速递结核与非结核分枝杆菌艾滋病与性传播感染

新型5转录本全血基因表达特征用于HIV感染者结核筛查

A Novel, 5-Transcript, Whole-blood Gene-expression Signature for Tuberculosis Screening Among People Living With Human Immunodeficiency Virus.
PubMed 文献 · Clin Infect Dis · 2019-01-01

本研究在乌干达坎帕拉HIV感染者结核筛查研究中,纳入40例培养确诊结核患者和80例时间匹配对照,随机分为训练集和测试集,开发出5转录本基因表达特征。该特征在独立测试集AUC为0.87,敏感性94%、特异性75%,优于4个已发表特征,并在高和低结核负担外部数据集中表现良好。

要点

  • 新型5转录本特征在HIV感染者结核筛查中AUC达0.87。
  • 测试集敏感性94%、特异性75%,满足筛查准确性阈值。
  • 4个已发表结核基因特征均未达到期望准确性阈值。

核心结论

  • 识别出首个用于结核筛查的基因表达特征,有望转化为即时检验以促进HIV感染者等高危人群的系统性结核筛查。

研究设计与样本

  • 研究纳入2013年7月至2015年4月乌干达坎帕拉HIV感染者结核筛查研究中40例培养确诊结核患者和80例时间匹配对照。

主要发现

  • 在独立测试集上,5转录本特征AUC为0.87(95%CI 0.72-0.98),敏感性94%、特异性75%。
  • 4个已发表结核基因表达特征均未达到期望准确性阈值。
  • 新特征在高结核负担外部数据集AUC为0.81(95%CI 0.74-0.88),低结核负担外部数据集AUC为0.81(95%CI 0.77-0.85)。

关键数值与推荐

  • 5转录本特征满足推荐的结核筛查试验准确性阈值。

临床怎么用

  • 该特征有潜力转化为即时检验,用于HIV感染者及其他高危人群的系统性结核筛查。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gene-expression profiles have been reported to distinguish between patients with and without active tuberculosis (TB), but no prior study has been conducted in the context of TB screening. METHODS: We included all the patients (n = 40) with culture-confirmed TB and time-matched controls (n = 80) enrolled between July 2013 and April 2015 in a TB screening study among people living with human immunodeficiency virus (PLHIV) in Kampala, Uganda. We randomly split the patients into training (n = 80) and test (n = 40) datasets. We used the training dataset to derive candidate signatures that consisted of 1 to 5 differentially-expressed transcripts (P ≤ .10) and compared the performance of our candidate signatures with 4 published TB gene-expression signatures, both on the independent test dataset and in 2 external datasets. RESULTS: We identified a novel, 5-transcript signature that met the accuracy thresholds recommended for a TB screening test. On the independent test dataset, our signature had an area under the curve (AUC) of 0.87 (95% confidence interval [CI] 0.72-0.98), with sensitivity of 94% and specificity of 75%. None of the 4 published TB signatures achieved desired accuracy thresholds. Our novel signature performed well in external datasets from both high (AUC 0.81, 95% CI 0.74-0.88) and low (0.81, 95% CI 0.77-0.85) TB burden settings. CONCLUSIONS: We identified the first gene-expression signature for TB screening. Our signature has the potential to be translated into a point-of-care test to facilitate systematic TB screening among PLHIV and other high-risk populations.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rajan JV, Semitala FC, Mehta T, et al. A Novel, 5-Transcript, Whole-blood Gene-expression Signature for Tuberculosis Screening Among People Living With Human Immunodeficiency Virus. Clin Infect Dis. 2019. PMID: 30462176. doi:10.1093/cid/ciy835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。